17856-0631-1 : NDC 2026 Code

17856-0631-1 : Atovaquone ( Atovaquone )

Additionally :

You can get information about “17856-0631-1” NDC code in 17856-0631-1 in HTML format

HTML | 17856-0631-1 in TXT (Plain Text) format

TXT | 17856-0631-1 in PDF (Portable Document Format)

PDF | 17856-0631-1 in XML format

XML formats.

NDC Code : 17856-0631-1 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "17856-0631-1",
    "PackageDescription": "72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2) ",
    "NDC11Code": "17856-0631-01",
    "ProductNDC": "17856-0631",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Atovaquone",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Atovaquone",
    "DosageFormName": "SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20181011",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA210692",
    "LabelerName": "ATLANTIC BIOLOGICALS CORP.",
    "SubstanceName": "ATOVAQUONE",
    "StrengthNumber": "750",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Antimalarial [EPC], Antiprotozoal [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-05-13",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20240904",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}